Novel polyetherurethaneureas containing tertiary amino groups in the side chains (PAEUU) were synthesized, quaternized with different alkyl halides (Q-PAEUU), and heparinized (H-PAEUU). The antithrombogenicity of PAEUU in uitro was improved by quaternization, and further by heparinization. The excel
A new antithrombogenic heparinized polymer
โ Scribed by Miyara, Hajime ;Harumiya, Noriho ;Mori, Yuichi ;Tanzawa, Hiroshi
- Publisher
- John Wiley and Sons
- Year
- 1977
- Tongue
- English
- Weight
- 567 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0021-9304
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
A new antithrombogenic polymer was synthesized by photoinduced graft copolymerization of both a hydrophilic polymer and a cationic polymer to hydrophobic poly (vinyl chloride) copolymer, and by quarternizing and heparinizing the obtained graft copolymer.
For polymers of various compositions obtained by the method described above, chemical composition, water absorption, membrane potential, and quantity of adsorbed heparin were determined and antithrombogenicity evaluated in vivo. Thus, it has been found that the polymer of excellent antithrombogenicity has a negative membrane potential, a moderate elution rate of heparin, adsorbs heparin in a quantity of approximately 15 wtโ%, and has a degree of water adsorption of about 30 wtโ%. Also, measurement of membrane potential was very useful for the estimation of the quantity of the adsorbed heparin and its change with time.
๐ SIMILAR VOLUMES
A new method was developed for evaluating kinetically the antithrombogenicity of materials. The amount of thrombus formed was measured gravimetrically at an appropriate interval of time after calcium chloride was added to ACD blood in contact with a test material. Graphic curves for thrombus formati
In vzvo and in vitro experiments described herein have demonstrated that the (:BH coating is antithrombogenic when placed on PVC, as tested in the blood system of rabbits for periods up to 2 weeks. In vitro clotting times cannot be correlated with the in vivo thrombogenicity of the same implants. Fo